Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Change in Acquisitions & Divestments (2022 - 2026)

Rallybio (RLYB) posted Change in Acquisitions & Divestments of $17.9 million for Q1 2026, up 62.73% sequentially from $11.0 million in Q4 2025, and down 0.56% YoY from $18.0 million in Q1 2025.

Rallybio (RLYB) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Rallybio has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $17.9 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 0.56% year-over-year to $17.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (down 42.53% YoY) and the FY2025 annual result came in at $46.5 million, down 44.96% from the prior year.
  • Change in Acquisitions & Divestments rose to $17.9 million in Q1 2026 per RLYB's latest filing, from $11.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $38.5 million in Q2 2023 and troughed at $7.5 million in Q2 2025.
  • A 5-year average of $23.5 million and a median of $22.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 75.15% in 2023, then sank 66.67% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $34.0 million in 2022, then dropped by 10.56% to $30.4 million in 2023, then tumbled by 48.2% to $15.8 million in 2024, then slumped by 30.16% to $11.0 million in 2025, then soared by 62.73% to $17.9 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $17.9 million, $11.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Rallybio 94.61 Mn 94.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 5.50 Mn
Jun 30, 2026 5.50 Mn
Mar 31, 2026 17.90 Mn
Mar 31, 2026 17.90 Mn
Dec 31, 2025 11.00 Mn
Dec 31, 2025 11.00 Mn
Sep 30, 2025 9.97 Mn
Sep 30, 2025 9.97 Mn
Jun 30, 2025 7.50 Mn
Jun 30, 2025 7.50 Mn
Mar 31, 2025 18.00 Mn
Mar 31, 2025 18.00 Mn
Dec 31, 2024 15.75 Mn
Dec 31, 2024 15.75 Mn
Sep 30, 2024 24.42 Mn
Sep 30, 2024 24.42 Mn
Jun 30, 2024 22.50 Mn
Jun 30, 2024 22.50 Mn
Mar 31, 2024 21.75 Mn
Mar 31, 2024 21.75 Mn